NASDAQ
Artemis Therapeutics Inc. (ATMS) has a price/sales ratio of 212821.89x as of Friday, May 22, 2026. This represents a 13203850.46% increase compared to its 12-month average of 1.61x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.